Efficacy and Safety of 300 IR Sublingual Immunotherapy (SLIT) Tablets in Children Suffering From Grass Pollen Rhinoconjunctivitis

NCT00409409 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

278

Enrollment

INDUSTRY

Sponsor class

Conditions

Allergy

Interventions

DRUG: 300 IR grass pollen allergen extract tablet
DRUG: Placebo tablet

Sponsor

Stallergenes Greer